Karagiannis T, Malandris K, Avgerinos I, et al
GLP-1RAs represent an important drug class for the treatment of T2D and offer marked reductions in plasma glucose levels with a low risk of hypoglycaemia, body weight reductions and a reduction in CVD in patients with high CVD risk
Studies have shown 26 that weight loss of up to 12.47 kg and 5.24 kg, respectively, can be achieved after more than 20 weeks of treatment with semaglutide 2.4 mg and liraglutide 3.0 mg
The effect of different amounts of cinnamon consumption on blood glucose in healthy adult individuals
157,158 Activation of the insulin or Insulin-like Growth Factor 1 (IGF-1) receptor can enhance insulin sensitivity, improve glucose absorption and utilization by cells, and potentially have positive effects on cardiovascular health and long-term energy balance
This shift caused by GLP-1 use is opening new opportunities for food companies to finally build the healthier food system weve long imagined," Siegel said